TOKYO, Feb 16, 2024--- Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced that they have obtained manufacturing and ...

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

Kirsty, Biocon's rapid-acting insulin, is the first FDA-approved interchangeable biosimilar to NovoLog in the US and will be ...

Viridian Therapeutics, Inc., a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, and Ypsomed AG, the leading developer ...

WebMD provides information about interactions between Humira(CF) Pen Psor-Uv-Adol HS Pen Injector Kit and antipsychotics-sibutramine.

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog, expanding their insulin ...

Successfully integrating SubQ therapies into oncology practice requires a comprehensive approach centered on education. It is essential that the entire care team—including physicians, nurses ...

“Compounded drugs are not FDA-approved, meaning that the safety and quality of these products are not regulated by the FDA,” ...

Novo Nordisk A/S. Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was published in The Lancet and presented at ...